CBRE Group, Inc.
123.30USD
-7.9400 (-6.05%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CBRE.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.65▼ | $2.79 | 2 | 9 |
| Next quarter | $1.53▲ | $1.5 | 0 | 1 |
| Current year | $7.84▲ | $7.73 | 10 | 1 |
| Next year | $8.84▼ | $8.87 | 0 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $1.95 | $2.05 | +0.10 (+5.0%) |
| 2026-06-30 | $1.47 | $1.56 | +0.09 (+5.8%) |
| 2026-03-31 | $1.13 | $1.61 | +0.48 (+42.1%) |
| 2025-12-31 | $2.68 | $2.73 | +0.05 (+2.0%) |
141 ratings from 20 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Evercore ISI Group | Maintained | Outperform | $168 $166 | Oct 23, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $174 $164 | Oct 9, 2026 |
| Evercore ISI Group | Maintained | Outperform | $175 $166 | Sep 28, 2026 |
| Barclays | Maintained | Overweight | $180 $183 | Aug 17, 2026 |
| UBS | Maintained | Buy | $185 $190 | Jul 30, 2026 |
| Evercore ISI Group | Maintained | Outperform | $169 $175 | Jul 30, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $158 $174 | Jul 30, 2026 |
| Barclays | Maintained | Overweight | $178 $180 | Jul 28, 2026 |
| Evercore ISI Group | Maintained | Outperform | $179 $169 | Jun 30, 2026 |
| Barclays | Maintained | Overweight | $175 $178 | May 5, 2026 |
| Evercore ISI Group | Maintained | Outperform | $163 $179 | Apr 24, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $170 $175 | Apr 24, 2026 |
| Barclays | Maintained | Overweight | $174 $175 | Apr 14, 2026 |
| Barclays | Maintained | Overweight | $192 $174 | Mar 13, 2026 |
| UBS | Upgraded from Neutral | Buy | $175 $185 | Feb 23, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $192 $170 | Feb 13, 2026 |
| Barclays | Maintained | Overweight | $190 $192 | Jan 13, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $185 $192 | Jan 8, 2026 |
| Keefe, Bruyette & Woods | Upgraded from Market Perform | Outperform | $168 $185 | Dec 15, 2025 |
| Barclays | Initiated | Overweight | $190 | Dec 2, 2025 |
| UBS | Maintained | Neutral | $165 $175 | Oct 24, 2025 |
| UBS | Maintained | Neutral | $146 $165 | Oct 10, 2025 |
| Keefe, Bruyette & Woods | Maintained | Market Perform | $167 $168 | Oct 9, 2025 |
| Morgan Stanley | Maintained | Overweight | $170 $180 | Oct 7, 2025 |
| JP Morgan | Maintained | Overweight | $143 $185 | Aug 26, 2025 |
76 filings from 20 insiders · 12 buy / 5 sell over 6m
Officers and directors of CBRE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| GIAMARTINO EMMA EOfficer | Sell | 2.3k | $148.29 | $334k | Aug 13, 2026 |
| DOELLINGER CHAD JOfficer | Sell | 228 | $148.29 | $34k | Aug 13, 2026 |
| KOHLI VIKRAMADITYAOfficer | Sell | 2.7k | $150.00 | $400k | Jul 29, 2026 |
| COBERT BETH FDirector | Gift | 2.1k | — | — | May 27, 2026 |
| SANJIV YAJNIKDirector | Gift | 2.1k | — | — | May 26, 2026 |
| GILYARD REGINALD HAROLDDirector | Gift | 2.1k | — | — | May 26, 2026 |
| GOODMAN SHIRA DDirector | Gift | 2.1k | — | — | May 26, 2026 |
| METCALFE GUYDirector | Grant | 1.9k | — | — | May 21, 2026 |
| SONI GUNJANDirector | Grant | 1.9k | — | — | May 21, 2026 |
| SANJIV YAJNIKDirector | Grant | 3.4k | — | $200k | May 21, 2026 |
| BOZE BRANDON BDirector | Grant | 2.7k | — | $110k | May 21, 2026 |
| COBERT BETH FDirector | Grant | 1.9k | — | — | May 21, 2026 |
| GILYARD REGINALD HAROLDDirector | Grant | 1.9k | — | — | May 21, 2026 |
| GOODMAN SHIRA DDirector | Grant | 1.9k | — | — | May 21, 2026 |
| LOPEZ GERARDO IDirector | Grant | 1.9k | — | — | May 21, 2026 |
| GIAMARTINO EMMA EChief Financial Officer | Sell | 2.3k | $130.74 | $294k | May 15, 2026 |
| DOELLINGER CHAD JOfficer | Sell | 107 | $140.35 | $15k | May 5, 2026 |
| DOELLINGER CHAD JOfficer | Sell | 587 | $130.06 | $78k | Mar 12, 2026 |
| GIAMARTINO EMMA EChief Financial Officer | Sell | 9.2k | $148.61 | $1.37M | Feb 26, 2026 |
| DOELLINGER CHAD JOfficer | Grant | 6.2k | — | — | Feb 25, 2026 |
No analyst notes on CBRE yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 7 | 1 | 0 | 0 | Buy1.69 |
| 1 mo ago | 5 | 7 | 1 | 0 | 0 | Buy1.69 |
| 2 mo ago | 5 | 7 | 1 | 0 | 0 | Buy1.69 |
| 3 mo ago | 5 | 7 | 1 | 0 | 0 | Buy1.69 |
Members whose judged calls on CBRE have played out most reliably.
No settled calls on CBRE yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice